Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Fresh Tracks Therapeutics Inc V.BBI


Primary Symbol: FRTX

Healthcare Biotechnology
Fresh Tracks Therapeutics, Inc. is not engaged in any business activities. The Company is in the process of dissolution.


OTCPK:FRTX - Post by User

Fresh Tracks Therapeutics Inc > PIPE investment case
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(9)
•••
Comment by kurt73on Nov 09, 2020 7:04pm
181 Views
Post# 31867653

RE:RE:RE:RE:PIPE investment case

RE:RE:RE:RE:PIPE investment caseTourmaline just bought Jupiter for 622 million debt included. They flow about 35 thousand boe/d. I know its not apples to apples but with pipe production about half that does that not equate to around $2 a share. Could there be a premium due to the land value? 
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities